ALCLS:EPA
Cellectis SA
€1.03
arrow_downward
-1.25%(-0.013) 1D
Nov 4, 5:35:28 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCLS...
Open
€1.04
High
€1.08
Low
€1.01
Mkt. cap
88.14M
Avg. vol.
351.83K
Volume
230.37K
52-wk high
€4.75
52-wk low
€0.90
EPS
-€0.58
Shares outstanding
72.09M
No. of employees
227
Open
€1.04
High
€1.08
Low
€1.01
Mkt. cap
88.14M
Avg. vol.
351.83K
Volume
230.37K
52-wk high
€4.75
52-wk low
€0.90
EPS
-€0.58
Shares outstanding
72.09M
No. of employees
227
News stories
From web sources and news partners
Yahoo Finance
·
6 hours ago
Monthly information on share capital and company voting rights
Profile
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina. Wikipedia
About Cellectis SA
CEOAndré Choulika
Employees227
Founded1999
Headquarters-
SectorBiotechnology
Industry-
Websitecellectis.com